Junli He - 11 Sep 2026 Form 4 Insider Report for Harvard Apparatus Regenerative Technology, Inc. (HRGN)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
25 Sep 2026, 10:51:57 UTC
Prior SEC filing
11 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Joseph Damasio, by power of attorney

Key filing fact

Junli He filed Form 4 for Harvard Apparatus Regenerative Technology, Inc. (HRGN) on 25 Sep 2026.

Key facts

  • This page summarizes Junli He's Form 4 filing for Harvard Apparatus Regenerative Technology, Inc. (HRGN).
  • 6 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 25 Sep 2026, 10:51.

Change

  • Previous filing in this sequence was filed on 11 Aug 2026.
  • Current net transaction value: +$394,459.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001728598 Primary reporting owner

He Junli

Relationship
CEO, Director
Address
C/O HREGEN, 84 OCTOBER HILL ROAD, SUITE 11, HOLLISTON
Signature
/s/ Joseph Damasio, by power of attorney
Signature date
25 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HRGN transaction

Common Stock

Conversion of derivative security

Transaction value
Shares
+683,725
Change %
+244%
Price
$1.05*
Shares after
964,300
Date
11 Sep 2026
Ownership
Direct
Footnotes
F1
HRGN transaction

Common Stock

Purchase

Transaction value
$380,000
Shares
+361,905
Change %
+38%
Price
$1.05
Shares after
1,326,205
Date
11 Sep 2026
Ownership
Direct
Footnotes
F2
HRGN transaction

Common Stock

Purchase

Transaction value
$14,459
Shares
+6,725
Change %
+0.51%
Price
$2.15
Shares after
1,332,930
Date
15 Sep 2026
Ownership
Direct
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HRGN transaction Derivative

Bridge Note (04/14/2026)

Conversion of derivative security

Transaction value
Shares
-310,000
Change %
-100%
Price
Shares after
0
Date
11 Sep 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
295,238
Exercise price
$1.05
Footnotes
F4, F5, F6
HRGN transaction Derivative

Bridge Note (05/13/2026)

Conversion of derivative security

Transaction value
Shares
-205,378
Change %
-100%
Price
Shares after
0
Date
11 Sep 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
195,598
Exercise price
$1.05
Footnotes
F4, F5, F6
HRGN transaction Derivative

Bridge Note (07/16/2026)

Conversion of derivative security

Transaction value
Shares
-202,533
Change %
-100%
Price
Shares after
0
Date
11 Sep 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
192,889
Exercise price
$1.05
Footnotes
F4, F5, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

On September 11, 2026, the Issuer entered into Securities Purchase Agreements with certain investors pursuant to which the investors purchased in a private placement an aggregate of 2,703,727 shares of common stock at a purchase price of $1.05 per share (the "Private Placement"), which closed on September 11, 2026. Included in the Private Placement, the Reporting Person acquired 683,725 shares of common stock in exchange for the conversion and cancellation of an aggregate of $717,911 of outstanding principal and accrued interest under bridge promissory notes previously issued by the Issuer to the Reporting Person on April 14, 2026, May 13, 2026 and July 16, 2026, pursuant to a Securities Purchase Agreement, dated as of September 11, 2026, between the Issuer and the Reporting Person. The shares issued to the Reporting Person were issued at the same $1.05 per share purchase price, and the notes were cancelled in full upon the closing.

Footnote F2

On September 11, 2026, the Reporting Person also purchased 361,905 shares of common stock of the Issuer in the Private Placement for an aggregate cash purchase price of $380,000, or $1.05 per share, pursuant to a Securities Purchase Agreement, dated as of September 11, 2026, between the Issuer and the Reporting Person, on the same terms as the other investors in the Private Placement.

Footnote F3

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions from September 15, 2026 to September 23, 2026. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Footnote F4

Each bridge note provided that, upon a qualified equity financing of the Issuer, the Reporting Person could elect to convert the full balance of the note (principal and accrued interest) into the equity securities sold in such financing at the per-unit price paid by the purchasers in the financing. Because the conversion price was not fixed until the closing of the Private Placement, the notes were not derivative securities prior to that date pursuant to Rule 16a-1(c)(6). The conversion price became fixed at $1.05 per share upon the closing of the Private Placement on September 11, 2026, and the Reporting Person converted the full balance of each note on that date.

Footnote F5

Represents the outstanding principal and accrued interest on the note as of September 11, 2026.

Footnote F6

The notes were convertible upon the closing of a qualified equity financing and were scheduled to mature on the earlier of the closing of the Issuer's next capital raise with gross proceeds of at least $5,000,000 or the first anniversary of the note's issue date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .